Fee Bengsch

BET Bromodomain Inhibition Promotes Anti-tumor Immunity by Suppressing PD-L1 Expression

Hengrui Zhu, Fee Bengsch, Nikolaos Svoronos et al. · Cell Reports · 2016 · 417 citations · Full text

Cancer Immunosurveillance, Pd-l1 Expression, Pd-l1 Signaling +10

Genetically Engineered Mouse Models of Pancreatic Cancer: The KPC Model (<i>LSL‐Kras^G12D/+;LSL‐Trp53^R172H/+;Pdx‐1‐Cre</i>), Its Variants, and Their Application in Immuno‐oncology Drug Discovery

Jae W. Lee, Chad A. Komar, Fee Bengsch et al. · Current Protocols in Pharmacology · 2016 · 196 citations · Full text

Cell type-dependent pathogenic functions of overexpressed human cathepsin B in murine breast cancer progression

Fee Bengsch, Achim Buck, Sira C. Günther et al. · Oncogene · 2013 · 105 citations · Full text

Tumor Biology, Breast Oncology, Medicine +5

CTLA-4/CD80 pathway regulates T cell infiltration into pancreatic cancer

Fee Bengsch, Dawson Knoblock, Anni Liu et al. · Cancer Immunology Immunotherapy · 2017 · 103 citations · Full text

Pancreatic Cancer, Immunology, Tumor Immunity +6

Deletion of Cysteine Cathepsins B or L Yields Differential Impacts on Murine Skin Proteome and Degradome

Stefan Tholen, Martin L. Biniossek, Martina Gansz et al. · Molecular & Cellular Proteomics · 2012 · 40 citations · Full text